ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DXCM DexCom Inc

124.20
-13.81 (-10.01%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
DexCom Inc NASDAQ:DXCM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -13.81 -10.01% 124.20 124.20 124.38 138.805 124.08 132.50 8,584,723 00:59:15

DexCom Schedules Third Quarter 2016 Earnings Release and Conference Call for November 1, 2016 at 4:30 p.m. Eastern Time

27/09/2016 1:00pm

Business Wire


DexCom (NASDAQ:DXCM)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more DexCom Charts.

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2016 financial results after market close on Tuesday, November 1, 2016. Management will hold a conference call to review the company's third quarter 2016 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and then “Events and Webcasts,” and will be archived there for future reference.

To listen to the conference call, please dial (888) 771-4371 (US/Canada) or (847) 585-4405 (International) and use the confirmation number "41665869" approximately five minutes prior to the start time.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by people with diabetes and by healthcare providers in the hospital.

DexCom, Inc.Steven R. Pacelli, 858-200-0200Executive Vice President, Strategy and Corporate Development

1 Year DexCom Chart

1 Year DexCom Chart

1 Month DexCom Chart

1 Month DexCom Chart

Your Recent History

Delayed Upgrade Clock